Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Expression data from prostate cancer cell lines C4-2B (enzalutamide sensitive) and C4-2B-MDVR (enzalutamide resistant) cells

ABSTRACT: Prostate cancer C4-2B cells were cultured in enzalutamide in a dose-escalation manner. After sixty passages cells were resistant to enzalutamide, with a specific sets of genes been deregulated. We performed global gene expression analysis by cDNA microarrays to identify genes responsible for enzalutamide resistance in C4-2B-MDVR cells. Enzalutamide resistant C4-2B-MDVR cells were selected from C4-2B cells during long time enzalutamide treatment. Genes responsible for enzalutamide resistance were identified using C4-2B vs. C4-2B-MDVR RNA extraction and hybridization on Affymetrix microarrays.

ORGANISM(S): Homo sapiens

SUBMITTER: allen Gao 

PROVIDER: E-GEOD-64143 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Json Xml
altmetric image

Publications

Intracrine Androgens and AKR1C3 Activation Confer Resistance to Enzalutamide in Prostate Cancer.

Liu Chengfei C   Lou Wei W   Zhu Yezi Y   Yang Joy C JC   Nadiminty Nagalakshmi N   Gaikwad Nilesh W NW   Evans Christopher P CP   Gao Allen C AC  

Cancer research 20150203 7

The introduction of enzalutamide and abiraterone has led to improvement in the treatment of metastatic castration-resistant prostate cancer. However, acquired resistance to enzalutamide and abiraterone therapies frequently develops within a short period in many patients. In the present study, we developed enzalutamide-resistant prostate cancer cells in an effort to understand the mechanisms of resistance. Global gene-expression analysis showed that the steroid biosynthesis pathway is activated i  ...[more]

Similar Datasets

Unknown Expression data from prostate cancer cell lines C4-2B (enzalutamide sensitive) and C4-2B-MDVR (enzalutamide resistant) cells
2015-04-09 | GSE64143 | GEO
Unknown Transcriptome analysis of enzalutamide-sensitive and -resistant C4-2B cells
2020-10-20 | GSE159548 | GEO
Unknown High-throughput profiling of mRNA from parental and Enzalutamide resistant C4-2b prostate cancer cell lines
2020-02-01 | GSE110802 | GEO
Unknown Combination treatment of PTUPB with enzalutamide in C4-2B MDVR cells
2022-11-02 | GSE216777 | GEO
Transcriptomics Expression data from prostate cancer cell lines C4-2B (docetaxel sensitive) and TaxR (docetaxel resistant) cells
2013-08-01 | E-GEOD-47040 | biostudies-arrayexpress
Genomics Transcriptome analysis of Enzalutamide-resistant C4-2B (C4-2B MDVR) cells treated with Indocin.
| PRJNA531908 | ENA
Unknown Transcriptome analysis of Enzalutamide-resistant C4-2B (C4-2B MDVR) cells treated with Indocin.
2019-09-29 | GSE129596 | GEO
Genomics Transcriptome analysis of enzalutamide-sensitive and -resistant C4-2B cells
| PRJNA669681 | ENA
Unknown Gene expression profile of control and enzalutamide-resistant C4-2 PCa cell line
2022-12-01 | GSE189966 | GEO
Unknown ChIP-seq from C4-2B (ENCSR585FQO)
2017-10-23 | GSE105753 | GEO